STOCK TITAN

[ARS] AN2 Therapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - AN2 Therapeutics, Inc.

ARS Filing - AN2 Therapeutics, Inc.

This filing is available as a PDF document.

Filing Type: ARS

Company: AN2 Therapeutics, Inc. (ANTX)

Acceptance Date: 2026-04-22T16:03:12.000Z

View PDF Document